Skip to main content
Premium Trial:

Request an Annual Quote

Eclipsebio eMERGE Platform

Eclipse Bioinnovations (Eclipsebio), a San Diego-based RNA genomics company, has launched its eMERGE platform for the characterization and optimization of RNA-based therapeutic products, including vaccines, protein and gene therapies, and monoclonal antibodies. eMERGE will enable the company's partners to obtain actionable insights into RNA-based drug products by providing detailed measurements of therapeutic translation, stability-influencing structure, RNA substance identity and integrity, and evaluations of LNP and storage effects. The platform can also provide guidance for precise optimizations to improve therapeutic efficacy including identification of optimal sequences for translation and stability, the company said.